1. Spectroscopic, Viscositic, DNA Binding and Cytotoxic Studies of Newly Synthesized Steroidal Imidazolidines
- Author
-
Ayaz Mahmood Dar, Shakir Khan, and Shamsuzzaman
- Subjects
Sociology and Political Science ,Stereochemistry ,medicine.medical_treatment ,Clinical Biochemistry ,Intercalation (chemistry) ,Antineoplastic Agents ,Apoptosis ,010402 general chemistry ,Imidazolidines ,01 natural sciences ,Biochemistry ,Steroid ,HeLa ,chemistry.chemical_compound ,Imidazolidine ,Neoplasms ,medicine ,Humans ,MTT assay ,Spectroscopy ,Gel electrophoresis ,biology ,010405 organic chemistry ,DNA ,biology.organism_classification ,0104 chemical sciences ,Molecular Docking Simulation ,Clinical Psychology ,Spectrometry, Fluorescence ,chemistry ,Docking (molecular) ,MCF-7 Cells ,Steroids ,Law ,Social Sciences (miscellaneous) ,HeLa Cells - Abstract
A series of new steroidal imidazolidine derivatives (4-6) were synthesized after reacting steroidal thiosemicarbazones with chloro ethylacetate in absolute ethanol. After characterization by spectral and analytical data, the interaction studies of compounds (4-6) with DNA were carried out by UV-vis, fluorescence spectroscopy, hydrodynamic measurements, molecular docking and gel electrophoresis. The compounds bind to DNA preferentially through electrostatic and hydrophobic interactions with Kb; 2.63 × 10(3) M(-1), 1.81 × 10(3) M(-1) and 2.06 × 10(3) M(-1), respectively indicating the higher binding affinity of compound 4 towards DNA. Gel electrophoresis demonstrated that compound 4 showed strong interaction during the concentration dependent cleavage activity with pBR322 DNA. The molecular docking study suggested the intercalation of imidazolidine moiety of steroid derivative in minor groove of DNA. During in vitro cytotoxicity, compounds (4-6) revealed potential toxicity against the different human cancer cells (MTT assay). The uptake of compound 4 by MCF-7 and HeLa cells was studied by confocal microscopy which determined cell shrinkage and hence leading to the apoptosis. The results revealed that compound 4 has better prospectus to act as cancer chemotherapeutic candidate which warrants further in vivo anticancer investigations.
- Published
- 2015